New appointment at Acura Pharmaceuticals
This article was originally published in Scrip
Acura Pharmaceuticals (US) has named Dr Albert Brzeczko vice-president of technical affairs. From 1999 until this year, Dr Brzeczko was vice-president of global pharma new product development and pharma technologies at the contract services group International Specialty Products.
You may also be interested in...
Regulatory pressure to fully approve the first COVID-19 vaccine in China is mounting as top officials tour an inspection agency and two leading manufacturers.
A proposed rule released last month by the US Department of Health and Human Services is the Trump administration’s “latest attempt to sabotage HHS programs,” wrote Jessica Schubel, a senior policy analyst for the Center on Budget and Policy Priorities. See what the policy expert said about it in her blog post here.
Helped by a hefty financing earlier this year, Bukwang subsidiary Contera Pharma is poised to speed ongoing multinational Phase II trials with its lead asset for Parkinson’s-associated dyskinesia by hiring CNS experts as new top executives, as the Korean firm looks to take it public in ground-breaking move.